4th Quarter - Report

ML STRATEGIES, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H. R. 1458, and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act; General issues pertaining to immunosupressives.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JEREMY RABINOVITZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1458 (111th), S. 565 (111th)

Trade (domestic/foreign) TRD

H. R. 6517, Omnibus Trade Act of 2010, miscellaneous trade provisions.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JEREMY RABINOVITZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6517 (111th)

Health Issues HCR

H. R. 2400, Strategies to Address Antimicrobial Resistance (STARR) Act; H. R. 6331, GAIN Act; Issues pertaining to the development of new antibiotics; H. R. 3276, American Medical Isotope Production Act; H. R. 6224, 21st Century ALERT Act; Issues pertaining to the orphan drug exemption to the 340 (B) program.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JEREMY RABINOVITZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2400 (111th), H.R. 3276 (111th), H.R. 6331 (111th), H.R. 6224 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.